Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Sunovion Submits sNDA to FDA for Use of APTIOM® for the Treatment of Partial-Onset Seizures in Child

americanpharmaceuticalreviewMarch 14, 2017

Tag: Sunovion , Seizures , FDA

PharmaSources Customer Service